Tech Nation

Monitoring patients without touching them; Roman Abramovich invests in Israeli firm; Forbes' Israeli startup faves.

Reuters

EarlySense wins FDA approval for high-tech patient monitoring device
EarlySense, whose medical monitoring devices don’t require physical contact with patients, won permission from the Food and Drug Administration last week to sell a gadget in the United States that monitors patients’ heart and respiratory rates while they’re seated. The product, Chair Sensor, was evaluated at Coffee Regional Medical Center in Georgia, where the company said it was able to determine when patients were deteriorating or at risk of falling. Moving hospital patients from their beds to chairs improves healing and reduces the risk of complications, especially soon after surgery, the Ramat Gan-based company said, adding that its device was the first capable of monitoring seated patients without physical contact. (TheMarker)

Abramovich invests in AcousticEye pipe inspection firm
Roman Abramovich, the Russian-Jewish billionaire who owns the Chelsea soccer club, has invested more than $2 million in AcousticEye, a company specializing in tube-and-pipe inspection technology in the oil, gas and power-generation industries. The Houston-based company, which houses its research and development center in Tel Aviv, said it would use the funding to accelerate product development, deployment and sales. AcousticEye was founded by Israelis Tal Pechter and Noam Amir; Amir is the company’s chief technology officer. Its chief executive, Yoav Harel, previously headed Orbotech’s operations in Europe and North America. (TheMarker)